Compugen (CGEN) Operating Margin (2009 - 2026)

Compugen's (CGEN) quarterly Operating Margin came in at 414.38% in Q1 2026, up 4683.0% year-on-year from 8.66% in Q1 2025, and up 397.86% quarter-over-quarter from 83.23% in Q4 2025.

Compugen (CGEN) Operating Margin (2009 - 2026) Analysis & Trends

Compugen has disclosed Operating Margin across 15 years of filings, most recently posting 414.38% for Q1 2026.

  • Operating Margin for Q1 2026 came in at 414.38%, up 4683.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 43.97% (up 9830.0% YoY), and the FY2025 annual result was 43.05%, up 9649.0% from the prior year.
  • Operating Margin came in at 414.38% for Q1 2026 at Compugen, up from 83.23% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 414.38% in Q1 2026 to a low of 2006.28% in Q2 2025.
  • The 5-year median for Operating Margin is 26.24% (2024), against an average of 182.43%.
  • Peak annual rise in Operating Margin reached 59194 bps in 2025, while the deepest fall reached 170196 bps in 2025.
  • Compugen's Operating Margin stood at 47.05% in 2022, then surged by 214 bps to 53.75% in 2023, then slumped by 1046 bps to 508.7% in 2024, then jumped by 116 bps to 83.23% in 2025, then surged by 398 bps to 414.38% in 2026.
  • The last three Operating Margin figures came in at 414.38% (Q1 2026), 83.23% (Q4 2025), and 417.4% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -6.43%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 38.10%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Compugen 189.59 Mn 97.83 Mn 352,000.00 414.38%

Historic Data

Download Data
DateValue
Mar 31, 2026 414.38%
Dec 31, 2025 83.23%
Sep 30, 2025 -417.40%
Jun 30, 2025 -2,006.28%
Mar 31, 2025 367.56%
Dec 31, 2024 -508.70%
Sep 30, 2024 26.24%
Jun 30, 2024 -304.33%
Mar 31, 2024 331.85%
Dec 31, 2023 53.75%
Dec 31, 2022 -47.05%
Sep 30, 2021 -105.55%
Dec 31, 2020 -454.55%
Sep 30, 2018 -42.72%
Mar 31, 2018 1.15%
Dec 31, 2016 -0.02%
Sep 30, 2016 -11,381.43%
Jun 30, 2016 -1,412.90%
Mar 31, 2016 -9,538.71%
Dec 31, 2015 -8.75%